Linn S. Oftedal
Stavanger, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Diagnostic Performance of the α-Synuclein Seed Amplification Assay for Dementia With Lewy Bodies: A Comparison Across 4 Laboratories.
Journal: Neurology
Published: January 28, 2026
Relationship of cognitive decline with glucocerebrosidase activity and amyloid-beta 42 in DLB and PD.
Journal: Annals of clinical and translational neurology
Published: June 27, 2024
Seed Amplification Assay as a Diagnostic Tool in Newly-Diagnosed Parkinson's Disease.
Journal: Journal of Parkinson's disease
Published: July 02, 2023
Early GCase activity is a predictor of long-term cognitive decline in Parkinson's disease.
Journal: Translational neurodegeneration
Published: March 09, 2023
Validation and assessment of preanalytical factors of a fluorometric in vitro assay for glucocerebrosidase activity in human cerebrospinal fluid.
Journal: Scientific reports
Published: August 07, 2020
Validation of a new assay for α-synuclein detection in cerebrospinal fluid.
Journal: Clinical chemistry and laboratory medicine
Published: May 11, 2016
The lipopeptide toxins anabaenolysin A and B target biological membranes in a cholesterol-dependent manner.
Journal: Biochimica et biophysica acta
Published: April 25, 2012
Anabaenolysins, novel cytolytic lipopeptides from benthic Anabaena cyanobacteria.
Journal: PloS one
Published: January 30, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026